1-(1,3-benzodioxol-5-ylcarbonyl)piperidine has been researched along with 6-cyano-7-nitroquinoxaline-2,3-dione in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambros-Ingerson, J; Arai, A; Kessler, M; Lynch, G; Rogers, G; Xiao, P | 1 |
1 other study(ies) available for 1-(1,3-benzodioxol-5-ylcarbonyl)piperidine and 6-cyano-7-nitroquinoxaline-2,3-dione
| Article | Year |
|---|---|
A centrally active drug that modulates AMPA receptor gated currents.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Dioxoles; Dose-Response Relationship, Drug; Evoked Potentials; Glutamates; Glutamic Acid; Hippocampus; Membrane Potentials; Organ Culture Techniques; Piperidines; Pyramidal Cells; Quinoxalines; Rats; Receptors, AMPA | 1994 |